Table 2.
Univariate analysis of the parameters of the PNBM and PNAM patients
| Variable | PNBM (226) | PNAM (255) | P |
|---|---|---|---|
| Age (years) | 48 (37, 59) | 45 (35, 56) | .814 |
| Male (%) | 121 (53.5) | 136 (53.3) | .971 |
| CSF biomarkers | |||
| C‐Cell (106/L) | 6529.0 (2107.0, 22 714.0) | 2509.0 (214.0, 22 741.0) | <.001 |
| C‐Leu (106/L) | 2064.0 (716.5, 7399.3) | 73.0 (10.0, 3060.0) | <.001 |
| C‐Neu (%) | 88.1 (80.5, 95.1) | 38.4 (0.0, 91.9) | <.001 |
| C‐Glu (mmol/L) | 1.6 (0.78, 2.80) | 3.4 (2.6, 4.3) | <.001 |
| C‐Pro (mg/dL) | 180.0 (98.0, 293.8) | 89.8 (42.8, 220.1) | <.001 |
| C‐Cl‐ (mmol/L) | 117.0 (111.9, 122.0) | 121.1(116.6, 124.8) | <.001 |
| C/B‐Glu | 0.25 (0.08, 0.44) | 0.64(0.45, 0.84) | <.001 |
| C‐Lac (μmol/L) | 5.1 (3.5, 8.0) | 2.7 (1.9, 4.2) | <.001 |
| Blood biomarkers | |||
| B‐Glu (mmol/L) | 6.6 (5.4, 9.0) | 5.0 (4.3, 6.4) | <.001 |
| B‐Leu (109/L) | 12.4 (9.4, 17.4) | 13.5 (9.5, 17.1) | .616 |
| B‐Neu (%) | 85.0 (77.2, 89.6) | 86.1 (75.6, 90.7) | .872 |
| RBC (1012/L) | 3.8 ± 0.7 | 4.1 ± 0.7 | <.001 |
| Hb (g/L) | 114.2 ± 22.1 | 120.3 ± 21.0 | .002 |
| PLT (109/L) | 230.5 (188.8, 286.0) | 236.0 (190.0, 295.0) | .738 |
P < .05 was considered to be significant.